NeurologyLive Friday 5 — June 5, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 5, 2020.
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
1: Peer Exchange: Differential Diagnosis of Multiple Sclerosis
The panel of Fred Lublin, MD; Wallace Brownlee, MBChB, PhD, FRACP; Patricia K. Coyle, MD; and Sven Meuth, MD, PhD, reviews multiple sclerosis guidelines for diagnosis and treatment and reviews the differential diagnosis of MS.
2: The Advantages of Independent Contact-Current Controlled DBS Devices
Jerrold L. Vitek, MD, PhD, professor and head of the department of neurology at the University of Minnesota, spoke to the recent findings of a study of Boston Scientific's multiple independent contact current-controlled device for deep brain stimulation.
3: CMSC 2020 Day 3: Mark Freedman, MSc, MD, on Stem Cell Research
The director of the Multiple Sclerosis Research Unit at Ottawa Hospital-General Campus, presents the John F. Kurtzke Lecture, titled "Stem Cell Research Update" as part of the 2020 CMSC Virtual Annual Meeting.
4: Novel BTK Inhibitor Evobrutinib Displays Long-Term Success in MS
Robert Henderson, PhD, vice president of Global Program Leadership in Neurology and Immunology at EMD Serono, discussed the recent long-term phase 2 data on evobrutinib presented at CMSC 2020. .
5: Shadi Yaghi, MD: Future Research on Stroke and COVID-19
The assistant professor and director of Clinical Vascular Neurology Research at NYU Langone shares his reaction to data that has been published and what needs to be researched going forward.
